MLV & Co Initiates Coverage on Cardiovascular Systems (CSII)

By admin | 6 years ago

Investment analysts at MLV & Co began coverage on shares of Cardiovascular Systems (NASDAQ: CSII) in a note issued to investors on Friday. The firm set a “buy” rating and a $17.00 price target on the stock.

Cardiovascular Systems opened at 9.32 on Friday. Cardiovascular Systems has a 1-year low of $7.26 and a 1-year high of $16.25. The company’s market cap is $169.6 million.

A number of other firms have also recently commented on CSII. Analysts at William Blair upgraded shares of Cardiovascular Systems from a “market perform” rating to an “outperform” rating in a research note to investors on Thursday, May 3rd. Separately, analysts at Dougherty & Co initiated coverage on shares of Cardiovascular Systems in a research note to investors on Wednesday, April 11st. They set a “buy” rating and a $14.50 price target on the stock. Finally, analysts at Benchmark Co. initiated coverage on shares of Cardiovascular Systems in a research note to investors on Tuesday, March 27th. They set a “buy” rating and a $15.00 price target on the stock.

Cardiovascular Systems, Inc. (CSI) is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease.

About the author